PACTR201706002208408Recruiting未知
Translating Research into Practice (TRIP): Evaluating and Speeding up the adoption of an evidenced based innovative REMSTART package to reduce mortality in advanced stage HIV patients starting antiretroviral therapy in Tanzania
iverpool School of Tropical Medicine (LSTM)0 sites620 target enrollmentStarted: April 14, 2017Last updated:
Conditions
Trial Snapshot
- Phase
- 未知
- Status
- Recruiting
- Sponsor
- Enrollment
- 620
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 Year(s) to 100 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •The inclusion criteria will be:
- •-CD4<200 cells /¿l
- •-Serum/plasma CrAg positive
- •-Lumbar puncture negative
- •-Adult: ¿18y or more.
- •-Antiretroviral naïve (as reported by the patient)
- •-Planning to remain in the study area for about 6 months (as reported by the patient)
Exclusion Criteria
- •The exclusion criteria will be:
- •-requiring immediate in-patient care / admission
- •-Pregnant or lactating
- •-If ALT > 5 times upper limit of normal
Investigators
Similar Trials
Recruiting
Not Applicable
Translational research associated with 'An investigator-initiated phase II trial of niraparib for patients with BRCA-mutated unresectable/recurrent biliary tract, pancreatic and other gastrointestinal cancer'biliary tract, pancreatic and other gastrointestinal cancersJPRN-UMIN000049452Hokkaido University Hospital60
Not yet recruiting
Unknown
Implementing Kangaroo Mother Care soon after birth in district hospitalsCTRI/2023/03/050420Centre for Health Research and Development Society for Applied Studies
Completed
Not Applicable
The use of health belief derived interventions to improve the ability of patients to take medicines for pulmonary arterial hypertensioPulmonary arterial hypertension (PAH)Circulatory SystemISRCTN41973090niversity of Bradford33
Recruiting
Phase 1
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C (CODEBREAK)locally-advanced and unresectable or metastatic NSCLC with KRAS G12CMedDRA version: 21.1Level: PTClassification code: 10061873Term: Non-small cell lung cancer Class: 100000004864MedDRA version: 25.1Level: LLTClassification code: 10069759Term: KRAS mutation Class: 10018065CTIS2024-510837-16-00Institut Gustave Roussy40
Active, not recruiting
Phase 1
An Interventional and Translational Study investigating Sotorasib in Previously Treated Locally Advanced or Metastatic non-small-cell lung cancerocally-advanced and unresectable or metastatic non-small-cell lung cancer with KRAS G12C mutationEUCTR2021-006958-31-FRGustave Roussy40